KDM8_MOUSE
ID KDM8_MOUSE Reviewed; 414 AA.
AC Q9CXT6;
DT 26-JUN-2007, integrated into UniProtKB/Swiss-Prot.
DT 01-JUN-2001, sequence version 1.
DT 03-AUG-2022, entry version 124.
DE RecName: Full=Bifunctional peptidase and arginyl-hydroxylase JMJD5 {ECO:0000250|UniProtKB:Q8N371};
DE EC=1.14.11.73 {ECO:0000250|UniProtKB:Q8N371};
DE EC=3.4.-.- {ECO:0000250|UniProtKB:Q8N371};
DE AltName: Full=JmjC domain-containing protein 5 {ECO:0000250|UniProtKB:Q8N371};
DE AltName: Full=Jumonji C domain-containing protein 5 {ECO:0000250|UniProtKB:Q8N371};
DE AltName: Full=L-arginine (3R)-hydroxylase KDM8 {ECO:0000250|UniProtKB:Q8N371};
DE AltName: Full=Lysine-specific demethylase 8;
GN Name=Kdm8 {ECO:0000312|MGI:MGI:1924285};
GN Synonyms=Jmjd5 {ECO:0000250|UniProtKB:Q8N371};
OS Mus musculus (Mouse).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC Murinae; Mus; Mus.
OX NCBI_TaxID=10090;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC STRAIN=C57BL/6J; TISSUE=Head;
RX PubMed=16141072; DOI=10.1126/science.1112014;
RA Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT "The transcriptional landscape of the mammalian genome.";
RL Science 309:1559-1563(2005).
RN [2]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC STRAIN=FVB/N; TISSUE=Mammary tumor;
RX PubMed=15489334; DOI=10.1101/gr.2596504;
RG The MGC Project Team;
RT "The status, quality, and expansion of the NIH full-length cDNA project:
RT the Mammalian Gene Collection (MGC).";
RL Genome Res. 14:2121-2127(2004).
RN [3]
RP FUNCTION, DISRUPTION PHENOTYPE, INTERACTION WITH CRY1; FBXL3 AND PSMD2, AND
RP TISSUE SPECIFICITY.
RX PubMed=30500822; DOI=10.1371/journal.pbio.2006145;
RA Saran A.R., Kalinowska D., Oh S., Janknecht R., DiTacchio L.;
RT "JMJD5 links CRY1 function and proteasomal degradation.";
RL PLoS Biol. 16:E2006145-E2006145(2018).
CC -!- FUNCTION: Bifunctional enzyme that acts both as an endopeptidase and 2-
CC oxoglutarate-dependent monooxygenase. Endopeptidase that cleaves
CC histones N-terminal tails at the carboxyl side of methylated arginine
CC or lysine residues, to generate 'tailless nucleosomes', which may
CC trigger transcription elongation. Preferentially recognizes and cleaves
CC monomethylated and dimethylated arginine residues of histones H2, H3
CC and H4. After initial cleavage, continues to digest histones tails via
CC its aminopeptidase activity. Upon DNA damage, cleaves the N-terminal
CC tail of histone H3 at monomethylated lysine residues, preferably at
CC monomethylated 'Lys-9' (H3K9me1). The histone variant H3F3A is the
CC major target for cleavage. Additionnally, acts as Fe(2+) and 2-
CC oxoglutarate-dependent monooxygenase, catalyzing (R)-stereospecific
CC hydroxylation at C-3 of 'Arg-137' of RPS6 and 'Arg-141' of RCCD1, but
CC the biological significance of this activity remains to be established.
CC Regulates mitosis through different mechanisms: Plays a role in
CC transcriptional repression of satellite repeats, possibly by regulating
CC H3K36 methylation levels in centromeric regions together with RCCD1.
CC Possibly together with RCCD1, is involved in proper mitotic spindle
CC organization and chromosome segregation. Negatively regulates cell
CC cycle repressor CDKN1A/p21, which controls G1/S phase transition.
CC Required for G2/M phase cell cycle progression. Regulates expression of
CC CCNA1/cyclin-A1, leading to cancer cell proliferation. Also, plays a
CC role in regulating alpha-tubulin acetylation and cytoskeletal
CC microtubule stability involved in epithelial to mesenchymal transition
CC (By similarity). Regulates the circadian gene expression in the liver
CC (PubMed:30500822). Represses the transcriptional activator activity of
CC the CLOCK-ARNTL/BMAL1 heterodimer in a catalytically-independent manner
CC (By similarity). Negatively regulates the protein stability and
CC function of CRY1; required for AMPK-FBXL3-induced CRY1 degradation
CC (PubMed:30500822). {ECO:0000250|UniProtKB:Q8N371,
CC ECO:0000269|PubMed:30500822}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=2-oxoglutarate + L-arginyl-[protein] + O2 = (3R)-3-hydroxy-L-
CC arginyl-[protein] + CO2 + succinate; Xref=Rhea:RHEA:56744, Rhea:RHEA-
CC COMP:10532, Rhea:RHEA-COMP:14712, ChEBI:CHEBI:15379,
CC ChEBI:CHEBI:16526, ChEBI:CHEBI:16810, ChEBI:CHEBI:29965,
CC ChEBI:CHEBI:30031, ChEBI:CHEBI:78294; EC=1.14.11.73;
CC Evidence={ECO:0000250|UniProtKB:Q8N371};
CC -!- COFACTOR:
CC Name=Fe(2+); Xref=ChEBI:CHEBI:29033;
CC Evidence={ECO:0000250|UniProtKB:Q8N371};
CC Note=Binds 1 Fe(2+) ion per subunit. {ECO:0000250|UniProtKB:Q8N371};
CC -!- SUBUNIT: Can form homodimers (via JmjC domain). Found in a complex with
CC RCCD1. Interacts (via N-terminus) with RCCD1 (via N-terminus); this
CC interaction stimulates H3K36me3 and H3K36me2 demethylation. Interacts
CC (via JmjC domain) with H3C1 (By similarity). Interacts with FBXL3 and
CC PSMD2 (PubMed:30500822). Interacts with CRY1 in a FBXL3-dependent
CC manner (PubMed:30500822). {ECO:0000250|UniProtKB:Q8N371,
CC ECO:0000269|PubMed:30500822}.
CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q8N371}.
CC Chromosome {ECO:0000250|UniProtKB:Q8N371}. Note=Colocalizes with
CC trimethylated 'Lys-9' of histone H3 (H3K9me3).
CC {ECO:0000250|UniProtKB:Q8N371}.
CC -!- TISSUE SPECIFICITY: Expressed in a circadian manner in the liver.
CC {ECO:0000269|PubMed:30500822}.
CC -!- DISRUPTION PHENOTYPE: Conditional knockout in liver leads to disruption
CC of circadian gene expression in the liver.
CC {ECO:0000269|PubMed:30500822}.
CC -!- CAUTION: The demethylase activity of JMJD5 is controversial.
CC Demethylase activity towards H3K36me2 was observed in vivo and in
CC vitro. In addition, demethylase activity towards H3K36me3 when in a
CC complex with RCCD1 has been observed. In contrast, in other studies,
CC JMJD5 was shown not to display any demethylase activity toward
CC methylated H3K36 nor toward other methyllysines in the N-terminal tails
CC of H3 and H4 in vitro. {ECO:0000250|UniProtKB:Q8N371}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AK014006; BAB29111.1; -; mRNA.
DR EMBL; BC024807; AAH24807.1; -; mRNA.
DR CCDS; CCDS21821.1; -.
DR RefSeq; NP_084118.1; NM_029842.5.
DR AlphaFoldDB; Q9CXT6; -.
DR SMR; Q9CXT6; -.
DR STRING; 10090.ENSMUSP00000033010; -.
DR iPTMnet; Q9CXT6; -.
DR PhosphoSitePlus; Q9CXT6; -.
DR EPD; Q9CXT6; -.
DR MaxQB; Q9CXT6; -.
DR PaxDb; Q9CXT6; -.
DR PRIDE; Q9CXT6; -.
DR ProteomicsDB; 268972; -.
DR Antibodypedia; 12808; 311 antibodies from 32 providers.
DR Ensembl; ENSMUST00000033010; ENSMUSP00000033010; ENSMUSG00000030752.
DR GeneID; 77035; -.
DR KEGG; mmu:77035; -.
DR UCSC; uc009jpz.2; mouse.
DR CTD; 79831; -.
DR MGI; MGI:1924285; Kdm8.
DR VEuPathDB; HostDB:ENSMUSG00000030752; -.
DR eggNOG; KOG2132; Eukaryota.
DR GeneTree; ENSGT00940000158074; -.
DR HOGENOM; CLU_016785_0_3_1; -.
DR InParanoid; Q9CXT6; -.
DR OMA; PPKWWHH; -.
DR OrthoDB; 1385616at2759; -.
DR PhylomeDB; Q9CXT6; -.
DR TreeFam; TF315056; -.
DR BioGRID-ORCS; 77035; 28 hits in 77 CRISPR screens.
DR PRO; PR:Q9CXT6; -.
DR Proteomes; UP000000589; Chromosome 7.
DR RNAct; Q9CXT6; protein.
DR Bgee; ENSMUSG00000030752; Expressed in pigmented layer of retina and 207 other tissues.
DR ExpressionAtlas; Q9CXT6; baseline and differential.
DR Genevisible; Q9CXT6; MM.
DR GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
DR GO; GO:0005829; C:cytosol; ISO:MGI.
DR GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR GO; GO:0016706; F:2-oxoglutarate-dependent dioxygenase activity; IBA:GO_Central.
DR GO; GO:0004177; F:aminopeptidase activity; ISO:MGI.
DR GO; GO:0003682; F:chromatin binding; ISS:UniProtKB.
DR GO; GO:0004175; F:endopeptidase activity; ISO:MGI.
DR GO; GO:0051864; F:histone H3-methyl-lysine-36 demethylase activity; ISS:UniProtKB.
DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR GO; GO:0035064; F:methylated histone binding; ISO:MGI.
DR GO; GO:0106157; F:peptidyl-arginine 3-dioxygenase activity; ISS:UniProtKB.
DR GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.
DR GO; GO:0032922; P:circadian regulation of gene expression; IMP:UniProtKB.
DR GO; GO:0000086; P:G2/M transition of mitotic cell cycle; ISS:UniProtKB.
DR GO; GO:0070544; P:histone H3-K36 demethylation; ISS:UniProtKB.
DR GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR GO; GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB.
DR GO; GO:0031648; P:protein destabilization; IMP:UniProtKB.
DR GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR InterPro; IPR041667; Cupin_8.
DR InterPro; IPR003347; JmjC_dom.
DR Pfam; PF13621; Cupin_8; 1.
DR SMART; SM00558; JmjC; 1.
DR PROSITE; PS51184; JMJC; 1.
PE 1: Evidence at protein level;
KW Aminopeptidase; Biological rhythms; Cell cycle; Chromatin regulator;
KW Chromosome; Dioxygenase; Hydrolase; Iron; Metal-binding; Nucleus;
KW Oxidoreductase; Protease; Reference proteome; Transcription;
KW Transcription regulation.
FT CHAIN 1..414
FT /note="Bifunctional peptidase and arginyl-hydroxylase
FT JMJD5"
FT /id="PRO_0000292011"
FT DOMAIN 269..414
FT /note="JmjC"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00538"
FT REGION 1..107
FT /note="Interaction with RCCD1"
FT /evidence="ECO:0000250|UniProtKB:Q8N371"
FT REGION 148..169
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT BINDING 236
FT /ligand="a protein"
FT /ligand_id="ChEBI:CHEBI:16541"
FT /ligand_part="N(omega)-methyl-L-arginine residue"
FT /ligand_part_id="ChEBI:CHEBI:65280"
FT /evidence="ECO:0000250|UniProtKB:Q8N371"
FT BINDING 270
FT /ligand="2-oxoglutarate"
FT /ligand_id="ChEBI:CHEBI:16810"
FT /evidence="ECO:0000250|UniProtKB:Q8N371"
FT BINDING 273
FT /ligand="a protein"
FT /ligand_id="ChEBI:CHEBI:16541"
FT /ligand_part="N(omega),N(omega)'-dimethyl-L-arginine
FT residue"
FT /ligand_part_id="ChEBI:CHEBI:88221"
FT /evidence="ECO:0000250|UniProtKB:Q8N371"
FT BINDING 273
FT /ligand="a protein"
FT /ligand_id="ChEBI:CHEBI:16541"
FT /ligand_part="N(omega)-methyl-L-arginine residue"
FT /ligand_part_id="ChEBI:CHEBI:65280"
FT /evidence="ECO:0000250|UniProtKB:Q8N371"
FT BINDING 316
FT /ligand="2-oxoglutarate"
FT /ligand_id="ChEBI:CHEBI:16810"
FT /evidence="ECO:0000250|UniProtKB:Q8N371"
FT BINDING 316
FT /ligand="a protein"
FT /ligand_id="ChEBI:CHEBI:16541"
FT /ligand_part="N(omega),N(omega)'-dimethyl-L-arginine
FT residue"
FT /ligand_part_id="ChEBI:CHEBI:88221"
FT /evidence="ECO:0000250|UniProtKB:Q8N371"
FT BINDING 316
FT /ligand="a protein"
FT /ligand_id="ChEBI:CHEBI:16541"
FT /ligand_part="N(omega)-methyl-L-arginine residue"
FT /ligand_part_id="ChEBI:CHEBI:65280"
FT /evidence="ECO:0000250|UniProtKB:Q8N371"
FT BINDING 319
FT /ligand="2-oxoglutarate"
FT /ligand_id="ChEBI:CHEBI:16810"
FT /evidence="ECO:0000250|UniProtKB:Q8N371"
FT BINDING 319
FT /ligand="Fe cation"
FT /ligand_id="ChEBI:CHEBI:24875"
FT /ligand_note="catalytic"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00538"
FT BINDING 321
FT /ligand="Fe cation"
FT /ligand_id="ChEBI:CHEBI:24875"
FT /ligand_note="catalytic"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00538"
FT BINDING 325
FT /ligand="2-oxoglutarate"
FT /ligand_id="ChEBI:CHEBI:16810"
FT /evidence="ECO:0000250|UniProtKB:Q8N371"
FT BINDING 334
FT /ligand="2-oxoglutarate"
FT /ligand_id="ChEBI:CHEBI:16810"
FT /evidence="ECO:0000250|UniProtKB:Q8N371"
FT BINDING 398
FT /ligand="2-oxoglutarate"
FT /ligand_id="ChEBI:CHEBI:16810"
FT /evidence="ECO:0000250|UniProtKB:Q8N371"
FT BINDING 398
FT /ligand="Fe cation"
FT /ligand_id="ChEBI:CHEBI:24875"
FT /ligand_note="catalytic"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00538"
FT BINDING 412
FT /ligand="2-oxoglutarate"
FT /ligand_id="ChEBI:CHEBI:16810"
FT /evidence="ECO:0000250|UniProtKB:Q8N371"
SQ SEQUENCE 414 AA; 47145 MW; 4C794D0F5E9EC996 CRC64;
MSEDTTEPLV GSSTLWKELR TLLPDKEEEL KLDLGEKVDR SVAALLRQAV GLFYAGHWQG
CLQASEAVLD YSWEKLNTGP WRDVDKEWRR VYSFGCLLKA LCLCQAPQKA TTVVEALRVC
DMGLLMGAAI LEDILLKVVA VLQTHQLPGK QPARGPHQDQ PATKKAKCDA SPAPDVMLER
MVPRLRCPPL QYFKQHFLVP GRPVILEGVA DHWPCMKKWS LQYIQEIAGC RTVPVEVGSR
YTDEDWSQTL MTVDEFIQKF ILSEAKDVGY LAQHQLFDQI PELKRDISIP DYCCLGNGEE
EEITINAWFG PQGTISPLHQ DPQQNFLVQV LGRKYIRLYS PQESEAVYPH ETHILHNTSQ
VDVENPDLEK FPKFTEAPFL SCILSPGDTL FIPAKYWHYV RSLDLSFSVS FWWS